Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Director departure
ANESIVA, INC. (ANSV) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/17/2009 8-K Quarterly results
12/09/2009 8-K Form 8-K - Current report
12/08/2009 8-K Form 8-K - Current report
12/04/2009 8-K Form 8-K - Current report
11/10/2009 8-K Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o...
10/30/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "ANESIVA ANNOUNCES DATE FOR 2009 ANNUAL MEETING OF STOCKHOLDERS TO VOTE ON PROPOSED MERGER"
10/23/2009 8-K Termination of a Material Definitive Agreement
09/25/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "ANESIVA RECEIVES NASDAQ LISTING COMPLIANCE NOTICE"
09/17/2009 8-K/A Other Events, Financial Statements and Exhibits
Docs: "Revised Form of presentation of Anesiva, Inc"
09/11/2009 8-K Other Events
08/25/2009 8-K Form 8-K - Current report
08/21/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/17/2009 8-K Cost Associated with Exit or Disposal Activities
08/05/2009 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Merger among Anesiva, Inc., Arca Acquisition Corporation, Arcion Therapeutics, Inc. and, with respect to Articles V and IX only, each of the Arcion stockholders listed on Schedule I",
"Registration Rights Agreement, by and among Anesiva, Inc. and the entities identified on Schedule A thereto",
"Amendment No. 2 to Securities Purchase Agreement, by and between Anesiva, Inc. and Sofinnova Venture Partners VII, L.P., Alta California Partners III, L.P., Alta Embarcadero Partners III, LLC, Alta Partners VIII, LP, CMEA Ventures VII, L.P., CMEA Ventures VII (Parallel), L.P., InterWest Partners VIII, LP, InterWest Investors VIII, LP, and InterWest Investors Q VIII, LP",
"Reinvestment Agreement, by and among Anesiva, Inc., Arcion Therapeutics, Inc., and Sofinnova Venture Partners VII, L.P., Alta California Partners III, L.P., Alta Embarcadero Partners III, LLC, Alta Partners VIII, LP, CMEA Ventures VII, L.P., CMEA Ventures VII (Parallel), L.P., InterWest Partners VIII, LP, InterWest Investors VIII, LP, and InterWest Investors Q VIII, LP",
"Amended and Restated Executive Change in Control and Severance Benefit Plan, as amended",
"Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement -Creates New Company Focused on Targeted Pain Therapeutics that Address Large Markets With Unmet Needs- -Conference Call Scheduled for Wednesday, August 5, 2009 at 8:30 AM EDT-"
07/23/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
07/09/2009 8-K Termination of a Material Definitive Agreement
06/09/2009 8-K Termination of a Material Definitive Agreement
05/22/2009 8-K Form 8-K -- Current report
04/28/2009 8-K Form 8-K -- Current report
04/02/2009 8-K Form 8-K -- Current report
03/20/2009 8-K Form 8-K -- Current report
03/06/2009 8-K Form 8-K -- Current report
02/19/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation and Consulting Agreement between Anesiva, Inc. and Jean-Frédéric Viret"
01/23/2009 8-K Form 8-K -- Current report
12/30/2008 8-K Form 8-K -- Current report
12/19/2008 8-K Form 8-K -- Current report
12/10/2008 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement
11/14/2008 8-K Form 8-K -- Current report
11/14/2008 8-K/A Triggering Events That Accelerate or Increase a Direct Financial Obligation under an Off-Balance Sheet Arrangement, Cost Asso...
11/10/2008 8-K Form 8-K -- Current report
10/06/2008 8-K Form 8-K -- Current report
09/03/2008 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Principal Officers; Election of Directors; Appoin...
Docs: "Separation and Consulting Agreement between Anesiva, Inc. and John X. Regan",
"Offer Letter between Anesiva, Inc. and William C. Houghton, M.D.",
"ANESIVA ANNOUNCES APPOINTMENT OF WILLIAM HOUGHTON, M.D. AS SENIOR VICE PRESIDENT AND CHIEF MEDICAL OFFICER",
"ANESIVA ACCELERATES ITS TRANSITION TO SPECIALTY PHARMA PAIN MANAGEMENT COMPANY"
08/08/2008 8-K Quarterly results
Docs: "ANESIVA ANNOUNCES SECOND QUARTER 2008 FINANCIAL RESULTS AND UPDATE"
07/23/2008 8-K Entry into a Material Definitive Agreement
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy